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Introduction
Memory complaints occur across the age span but increase with advancing age (1, 2) and are a common reason for seeking medical help. In recent years media and public attention towards memory complaints has increased due following the development of National Dementia Strategies in many countries and politicians pledging to defeat dementia (e.g. (3)). These policies aim to improve the detection of dementia, in particular Alzheimer's disease (AD), at the earliest time possible. However, for these strategies to be most effective, accurate screening by General Practitioners and early distinction of progressive neurodegenerative memory problems from other causes of memory complaints is required. There is evidence that, at present, screening procedures are not working well and that the proportion of patients without dementia is increasing in memory clinics (4) (5) (6) The label 'Functional Memory Disorder' (FMD) has been proposed to describe those patients who experience subjective memory complaints and present to memory clinics but do not have an underlying neurodegenerative or psychiatric cause (7) . Diagnostic criteria for FMD have been proposed by Schmidtke and colleagues (8) , and include subjective memory complaints that affect functioning in everyday life, have been present for more than 6 months, and cannot be explained by a clear psychiatric cause. Whilst there is debate on how these research criteria could be utilised in clinical practice (9) , they can be used as a basis for diagnosing those patients who come to the memory clinics but who do not fit criteria for a memory complaint compatible with a neurodegenerative aetiology. Patients with functional disorders are not exclusive to memory clinics, and are commonly seen in general neurology clinics (10) . In a review of functional neurological symptoms by Carson and colleagues (11) , it was noted that UK neurologists find these patients the hardest to treat (12) . Previously, a functional neurological diagnosis was reached after excluding other 'organic causes', but more recent attempts have been made to provide positive diagnostic criteria for functional neurological disorders. The Diagnostic and Statistical manual of Mental Disorders 5 (DSM-5) utilises lack of consistency and positive or objectifiable signs to diagnose Somatic Symptom Disorder (SSD). For example, clinicians reached the diagnosis of functional weakness in 14% of patients without further investigations by the objectifiable detection of profound weakness of hip extension but good hip extension power when testing contralateral hip flexion power (Hoover's sign) (13).
Amariglio and colleagues (14) investigated specific memory complaints and reported that a 'change in memory' was the most common complaint. However, the least common type of complaint -'getting lost in familiar surroundings' (reported by only 1.6% of participants) -correlated with impairment on tasks failed by patients with AD, i.e., delayed recall, category fluency and confrontation naming. Furthermore, the complaint most associated with normal ageing, i.e., 'forgetting something one second to the next', showed no relationship with the cognitive tests administered to the sample (15) . Therefore, specific memory complaints may be useful indicators of both FMD and early neurodegeneration. It is extremely important, however to detect genuine cases of Mild Cognitive Impairment (MCI) prodromal to AD (16) in order to provide support for patients and families and to test the efficacy of new medications. However, distinguishing MCI due to AD from normal ageing can be difficult (16) . Detailed and extensive neuropsychological testing, however, can achieve high diagnostic accuracy. Specific patterns of performance on neuropsychological tests (for example, impaired semantic memory, tested using category fluency tasks) have been established as a useful early marker of AD while semantic memory remains fairly stable across the lifespan(17) unlike the decline in episodic memory (18) . Measuring semantic memory in the presence of memory complaints can more accurately separate healthy ageing from prodromal AD (19) .
A novel way to further analyse performance on the category fluency task has been through the extended analysis of the latent lexical attributes of each exemplar produced (e.g., Age of Acquisition (AoA) (20) , typicality (21) ). This approach appears useful in discriminating normal from pathological ageing seen in MCI and AD (20) . To the best of our knowledge, the diagnostic usefulness of detailed neuropsychological testing and that of lexical parameter analysis have not been studied in people with FMD and represents a useful avenue to pursue.
The aim of the current study was to establish whether there is a specific neuropsychological profile that characterises patients with FMD and would differentiate this patient group from healthy individuals on the one hand and from patients with mild neurodegenerative cognitive syndromes (a-MCI) on the other. Specifically, we expected that an extensive lexical semantic analysis of items produced on a category fluency task would help with this differentiation.
Material and Methods

Research Participants
Data from patients who attended a tertiary assessment NHS based memory clinic were included in the study. All patients had undergone neurological assessment and extensive neuropsychological testing.
Twenty patients diagnosed with FMD were included in this study, and this diagnosis was made when patients reported memory symptoms without any evidence of an organic neurodegenerative disease and in the absence of significant active psychiatric morbidity (e.g. general anxiety disorder, Clinical interview data from the neuropsychological report were searched for educational attainment, professional career status and for features of potential precipitating psychosocial stressors.
Twenty healthy adult controls with no subjective memory complaints were matched for age and education. The controls were selected from a large sample of participants who had been involved in a large standardisation study of a battery of neuropsychological tests and had undergone thorough background health screening before enrolment in that study FMD and a-MCI patients were selected among consecutive referrals to a memory clinic for tertiary assessment. When considering patients and controls for inclusion in this retrospective study, care was taken to match as closely as possible the FMD, MCI and healthy control participants for demographic variables such as age, gender, and education, although perfect matching for education across the three groups was not possible. For all patients included in this study, long term follow-up assessments are available and their diagnostic status has been clinically confirmed. This study was carried out according to the Declaration of Helsinki and was approved by the Regional Ethics Committee for Yorkshire and Humber. Written informed consent for retrospective analyses of their data was obtained from each study participant.
Tasks and Procedure
All participants had a detailed assessment by a clinician experienced in diagnosing neurodegenerative dementia and underwent structural brain imaging. The neuropsychological battery included a global screening measure (MMSE) as well as tests of language, memory, attention, executive functioning and visuospatial ability (for details of tests, please refer to table 1). In addition to the number of items produced on the category fluency task, an additional score was derived by calculating the mean (arithmetic mean) age of acquisition (AoA) score. AoA values were obtained from ratings acquired by an earlier study (23) . To control for the number of words produced, the AoA analysis was repeated including the mean AoA score for only the first 5 words produced in each category ('animals' and 'fruits') with an AoA score generated based on a total of 10 words.
Statistical Analyses
Analyses of individual scores from the neuropsychological test battery completed by patients and controls were done using ANCOVAs (between subject factor: group [FMD, controls, a-MCI]; covariate: education). To control for multiple comparisons, the significance value was lowered to p < 0.0026.
Results
Demographics
There were no significant age differences between the controls and either patient group, or between the patient groups ( Table 1) . The FMD patients and healthy controls differed significantly from the a-MCI (p<0.016 & p<0.005 respectively) in years of formal education, but not from each other. Table 2 shows the mean scores (and standard error) achieved by each group on the neuropsychological tests used in the battery. Significant between groups differences are highlighted by symbols.
-Insert Tables 1 and 2 about here -
FMD patients vs. Controls
The FMD patients did not differ from the healthy control group in terms of cognitive ability on any aspect of the neuropsychological battery in univariate or multivariate analyses.
Focusing on the age of acquisition analysis, there were no significant differences seen between the FMD patients and the control group, either in terms of total count or when the analysis was restricted to the first 10 words produced in this test.
FMD patients vs. a-MCI patients
The FMD patients significantly outperformed the a-MCI patient group on several tasks in the battery. Specifically, those centred on the memory and language domains. Significant differences were seen on tasks assessing global cognition (MMSE: p<0.001), memory (verbal paired associates: p<0.0001), and category fluency (category fluency task: p<0.001) (see Table 2 ).
Focusing on the AoA analysis, the FMD patients produced words that were higher in AoA value (i.e., acquired later in life) at p<0.0001 for both the total word count and the first ten word analysis, indicating that the total result was not an artefact of the FMD patients producing more words overall on this task (see Table 2 ).
Control group vs. a-MCI patients
Similarly to the FMD patients, the control group also outperformed the a-MCI patients on global cognition, memory (verbal and non-verbal domains), and category fluency. Focusing on the AoA analysis between these two groups, the controls produced words that were higher in AoA value (p<0.0001) compared to the a-MCI patients, again on both the total words and first 10-word analysis (see Table 2 ).
Discussion
In this study the neuropsychological profile of functional memory disorder patients was compared with those of a group of amnestic MCI patients and one of control participants without memory complaints, to investigate whether distinctive cognitive changes could be detected through an extensive battery of tests designed to reveal the earliest signs of neurodegeneration. As a group, functional memory patients reported subjective memory concerns for various reasons, including worrying about incipient dementia. At the individual level, verbal accounts of their memory failures were extensive and detailed. However, despite their subjective complaints no evidence was found in their neuropsychological profile or the comparison of the performance of FMD patients and healthy controls to suggest the presence of any objective memory impairment, especially not one suggestive of an early neurodegenerative disease.
Amnestic-MCI patients are of great interest because this state can be a transitional ("prodromal") state that has a higher conversion rate to AD compared to non-amnestic MCI (15) .
There were many significant differences in the neuropsychological profile of a-MCI patients and FMD patients, in particular in tasks assessing domains that have previously been recognised as early indicators of underlying neuropathology, for example, short-term and long-term memory (both verbal and visual) and category fluency (17) . Semantic memory and the associated lexical characteristic analysis are useful in the early detection of abnormal ageing in MCI (e.g., (20) ) and are also early indicators of AD neuropathology (24, 25) . In the current study, no difference was found between FMD patients and healthy controls in the AoA analysis. In contrast, the profile was significantly different between the two patient groups, providing supporting evidence that the memory complaints of FMD patient are not caused by an underlying neurodegenerative process, given the evidence that this latent variable is particularly sensitive to the earliest changes in mediotemporal cortex caused by AD pathology (24, 25) .
On tests of attention and executive control, such as the digit cancellation task, Stroop task, although not significantly different from each other, the control group did perform better than the FMD group. A similar finding has also been reported by Metternich et al (26) , who noted that it could be the calm testing environment that removes the significant differences between these groups and that distractedness in the real environment could distinguish normal healthy individuals from FMD individuals. Detection of these subthreshold differences between healthy ageing individuals and those with FMD could be a potential avenue for future research with larger samples. Questions to answer include what the reason for this difference is, and whether there are any functional or anatomical findings to support this view. For example, people with depression have dysfunction in frontal subcortical circuits (27) . There are five frontal subcortical circuits that are disrupted in some forms of neurodegeneration, but also in some psychiatric disorders, and underlie different phenotypes several related to memory and attention (28) . Patients who present with a fugue state, (memory disorder related to mood, and stress) typically have normal structural brain imaging but detailed neuropsychological and neuro-radiological investigation of an individual suggested micro-structural changes in white matter fibre tracts in the right prefrontal lobe (29) .
Retrospective descriptive analysis of data extracted from the contemporaneous neuropsychology clinic records suggests that life events (e.g., changes at work, family relationship strains) might significantly and insidiously affect the day-to-day lives of the FMD group with no conscious awareness by the patients themselves. For example, when attention is removed from the task at hand (e.g., going into a room to retrieve an item) or even subconsciously, by being focussed on a life event, a resulting attentional slip (i.e., forgetting what the particular item was) can prompt people with FMD to misattribute these memory lapses to neuropathology. This can cause greater rumination and worry about memory slips as described in Schmidtke, Metternich and colleagues' work (8, 26) . Previous research has also shown that subjective memory complaints are frequently caused by psychiatric disorders, most commonly by a depressive disorder, and these patients are often seen in memory clinics (30) . Investigating the psychosocial determinants of forgetfulness in persons aged between 53 and 94 (mean age = 72 years), Mol and colleagues (31) found that 'low memory selfefficacy, negative attitude, high memory related anxiety and high subjective norm' (i.e., what others in society think about memory failures) all contributed to a person's perceived forgetfulness.
There has been a steep increase in people referred to secondary care memory clinics (32, 33) and steady rise in the number of patients with FMD referred to memory clinics(4-6) is of concern, in terms of expense and potential harm of people with FMD suffering increased anxiety by attending a memory clinic (34) . Efforts should be made to detect FMD at primary care level. The reason for this increase may be multifactorial. For example, the increase in media attention over dementia and early dementia diagnosis might have prompted more people to report to GP services. GP uncertainty in diagnosis of functional patients may in turn generate more referrals to specialist memory clinics.
There is therefore a need for possible screening tools, which can be used in primary care to investigate cognitive impairment, and therefore limiting the potential harm of over-diagnosing or over-referring people to memory clinics (35) . Without neuropsychology and the experience of specialists, this task is particularly difficult. The addition of semantic memory tasks (e.g., category fluency) to the short screening tests such as the Six Item Cognitive Impairment Test (6CIT), which, although widely used in primary care, lacks sufficient sensitivity or specificity (36) may help distinguish FMD from neurodegenerative disorders such as early AD. Also recent research has focused on the use of conversation analysis for this purpose (37, 38) , whereby conversations between patients, neurologists and accompanying persons were analysed to identify specific interactions that can be useful to distinguish FMD and early organic patients.
Other factors that may be useful positive indicators of FMD include educational attainment level and certain personality traits, such as over achievement or perfectionism that can be conducive to worry that accompanies occasional attentional slips or memory failures (8) . A vicious circle can enhance these concerns in FMD patients. In our current study, we noted that 13 of our FMD group had achieved post high school education, with 7 of those also having University level education, supporting previous work (8, 39) . Furthermore, high career achievement was also reported in the majority of FMD patients, which included several business owners and management positions.
However, similar professions and high education was seen in the healthy controls who participated in this study. A possible route for treatment would be to investigate psychosocial risk factors (39) and explore beliefs about memory failures. We noted in clinical communications between the neuropsychologist and the patient, that only one person admitted that mood (in this case, anxiety) could be the cause of their subjective memory concerns, which supports research in functional weakness patients (13) . Memory complaints in FMD are similar to those experienced by many healthy ageing people (e.g., forgetting PIN numbers, getting lost mid-conversation, forgetting the reason for walking into a room). However they are more severe, or rather the perception of these memory failures is greater. Reassurance that their subjective memory complaints are not found on objective testing, may not be effective in all FMD patients (8) . As found in this study, subjective memory concerns can occur for many different reasons depending on the individual patient -from fear of dementia (40, 41) with increasing age or family history, to possible personality factors, and to an increase in stressful life events. Furthermore, a person's attitude, in particular their negative attitude, towards their memory could be a way to target treatment (42) , although a multidisciplinary therapeutic approach is likely the best option (39) .
The relationship between subjective memory complaints and psychiatric conditions/affective disorders, such as depression or anxiety, is an interesting avenue of further studies with FMD patients, but in this study we excluded those with severe and chronic depressive disorders to have a "pure" sample. Greater awareness of FMD is required by primary and secondary care in order to devise better screening tools that will distinguish these patients from those with signs of an early neurodegenerative disease.
